Qvella scores $20 mln Series A

Canadian molecular diagnostics company Qvella has secured $20 million in Series A funding. RA Capital Management and Whitecap Venture Partners led the round with participation from other investors that included Hatteras Venture Partners and Sands Capital Ventures. According to the company, the capital infusion will be used for personnel hiring and product development.

North AmericaUSBriefs